Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05482906

Common and Specific Information From Neuroimaging and Smartphone

Individual Gait Pattern and MRI Lesion Load to Quantify Gait Impairment in MS: A Cross Sectional Study.

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Gait alteration is frequent in MS and limitation in walking ability is a major concern in MS patients. Umanit and LMJL (Nantes university) has developed a device call egait to assess walking ability in individuals (eg MS patients).

Detailed description

This device consists in a commercialized IMU sensor (MetaMotionR Sensor, Mbientilab) worn at the right hip, a smartphone app and dedicated algorithm/mathematical model to extract raw sensor data and calculate individual gait pattern (IGP). This IGP consists of a curve, based on quaternion and representing the rotation recorded by the IMU during an average gait cycle. Pursue previous works conducted on (IGP to assess) gait alteration in MS by adding (to IGP) new information from MRI.

Conditions

Interventions

TypeNameDescription
OTHEReGaitIMU sensor (as part of eGait device) worn at the hip during T25FW

Timeline

Start date
2023-04-03
Primary completion
2026-04-30
Completion
2026-06-30
First posted
2022-08-01
Last updated
2026-03-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05482906. Inclusion in this directory is not an endorsement.